Medfinder
Expert medication guides

The Found Script

Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

Browse all articles A–Z →
Medication bottle with educational information icon
Drug Guides

What Is Eplerenone? Uses, Dosage, and What You Need to Know in 2026

Eplerenone (Inspra) is an aldosterone blocker used for heart failure after heart attack and high blood pressure. Here's everything you need to know in 2026.

By Peter Daggett·
What Is Carbidopa/Levodopa XR? Uses, Dosage, and What You Need to Know in 2026
Drug Guides

What Is Carbidopa/Levodopa XR? Uses, Dosage, and What You Need to Know in 2026

Carbidopa/Levodopa XR is an extended-release Parkinson's medication. Learn what it's used for, how to take it, dosage info, costs, and key facts for 2026.

By Peter Daggett·
Brimonidine Side Effects: What to Expect and When to Call Your Doctor
Side Effects & Safety

Brimonidine Side Effects: What to Expect and When to Call Your Doctor

Learn about common and serious Brimonidine side effects, who's most at risk, how to manage them, and when to call your doctor right away.

By Peter Daggett·
Alternatives to Tamsulosin If You Can't Fill Your Prescription
Alternatives & Substitutes

Alternatives to Tamsulosin If You Can't Fill Your Prescription

Can't fill your Tamsulosin prescription? Learn about safe alternatives for BPH including Alfuzosin, Silodosin, Doxazosin, and Finasteride.

By Peter Daggett·

43,000+ have already found their meds with Medfinder.

Stop calling pharmacies. Start your search today.

How Does Veozah Work? Mechanism of Action Explained in Plain English
Drug Guides

How Does Veozah Work? Mechanism of Action Explained in Plain English

Veozah works by blocking the NK3 receptor in your brain's thermostat to reduce hot flashes without hormones. Here's how it works in plain English.

By Peter Daggett·
Alternatives to Qulipta If You Can't Fill Your Prescription
Alternatives & Substitutes

Alternatives to Qulipta If You Can't Fill Your Prescription

Can't get Qulipta? Explore the best alternatives for migraine prevention in 2026, including Nurtec, Aimovig, Ajovy, and Emgality.

By Peter Daggett·
Large medication capsule with information icon — what is Retacrit
Drug Guides

What Is Retacrit? Uses, Dosage, and What You Need to Know in 2026

Retacrit (epoetin alfa-epbx) is a biosimilar ESA that treats anemia from CKD, chemotherapy, and HIV. Here's everything you need to know about it in 2026.

By Peter Daggett·
Biktarvy Side Effects: What to Expect and When to Call Your Doctor
Side Effects & Safety

Biktarvy Side Effects: What to Expect and When to Call Your Doctor

Learn about Biktarvy's common and serious side effects, who's at higher risk, how to manage them, and when you should call your doctor right away.

By Peter Daggett·
How Does Adderall XR Work? Mechanism of Action Explained in Plain English
Drug Guides

How Does Adderall XR Work? Mechanism of Action Explained in Plain English

How does Adderall XR work in your brain? Learn the mechanism of action explained in plain English, plus how long it takes to work and how it compares to similar meds.

By Peter Daggett·
Cobenfy medication illustration
Side Effects & Safety

Cobenfy Side Effects: What to Expect and When to Call Your Doctor

Learn the most common and serious side effects of Cobenfy, why they happen, which side effects go away over time, and when you should call your doctor right away.

By Peter Daggett·
How to Find Lyllana in Stock Near You (Tools + Tips)
Finding Medications

How to Find Lyllana in Stock Near You (Tools + Tips)

Struggling to find Lyllana in stock? Here are 3 proven tips to locate Estradiol patches near you, including pharmacy tools and insider strategies.

By Peter Daggett·
Adalimumab Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Adalimumab Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused briefing on adalimumab availability, biosimilar landscape, formulary shifts, and practical tools for ensuring patient access in 2026.

By Peter Daggett·
PreviousPage 81 of 1521Next